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Abstract
Throughout evolution, one of the most ancient forms of aggression between cells or organisms has been the production
of proteins or peptides affecting the permeability of the target cell membrane. This class of virulence factors includes the
largest family of bacterial toxins, the pore-forming toxins (PFTs). PFTs are bistable structures that can exist in a soluble and
a transmembrane state. It is unclear what drives biosynthetic folding towards the soluble state, a requirement that is
essential to protect the PFT-producing cell. Here we have investigated the folding of aerolysin, produced by the human
pathogen Aeromonas hydrophila, and more specifically the role of the C-terminal propeptide (CTP). By combining the
predictive power of computational techniques with experimental validation using both structural and functional
approaches, we show that the CTP prevents aggregation during biosynthetic folding. We identified specific residues that
mediate binding of the CTP to the toxin. We show that the CTP is crucial for the control of the aerolysin activity, since it
protects individual subunits from aggregation within the bacterium and later controls assembly of the quaternary pore-
forming complex at the surface of the target host cell. The CTP is the first example of a C-terminal chain-linked chaperone
with dual function.
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Introduction
Many organisms, as diverse as bacteria, parasites, sea anemones
or plants, produce membrane damaging proteins to protect
themselves or to modify the behavior of their host [1]. Amongst
these pore-forming proteins (PFPs), we find bacterial pore-forming
toxins (PFTs). These are produced as soluble proteins that diffuse
and bind to target cells via specific receptors. Many subsequently
assemble into ring-like structures [2], undergoing a conformational
change with consequent exposure of hydrophobic surfaces. This
drives spontaneous membrane insertion, leading to the formation
of water filled pores.
This peculiarity of PFTs, and PFPs in general, raises two
interesting questions. The first is: since PFPs can adopt two quite
different conformations, how is the folding reaction during
biogenesis directed towards obtaining the soluble fold? The
second question is: what mechanisms prevent pore-formation
from occurring in the producing cell? To address these related
questions, we have chosen the PFT aerolysin (for review see [2]).
Aerolysin is produced by the human pathogen Aeromonas hydrophila
as an inactive precursor called proaerolysin. Conversion of
proaerolysin to aerolysin involves proteolytic cleavage of a flexible
43-residue loop near the C-terminus (Figure 1A and Figure S1A).
Maturation occurs after secretion from the bacterium and
processing by gut enzymes or proteases present at the target cell
surface [3,4]. Since cleavage is essential for pore formation, it has
been proposed that the role of the 43-residue C-terminal peptide
(CTP) is to prevent premature oligomerization by steric hindrance,
particularly within the producing bacterium.
Our aim was to address the precise role of the CTP by
combining computational techniques, site-directed mutagenesis,
structural analysis, and functional assays. Our study reveals that
the CTP drives the protein into the soluble state during biogenesis,
protecting proaerolysin from aggregation possibly by promoting
folding, a quite unexpected observation considering the C-
terminal location of the peptide. Interestingly, mutagenesis of
specific residues in the CTP not only affected the efficiency of
proaerolysin folding both in vitro and in vivo, but also reduced the
capacity of the CTP to prevent premature assembly of the
heptamer, highlighting the dual role of the CTP in 1) preventing
aggregation of the newly synthesized protein possibly by assisting
folding, and 2) controlling the quaternary assembly of the active
complex.
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Results
Covalent bonding is not required for binding of the CTP
to aerolysin
The crystal structure of proaerolysin has been solved at 2.8 A˚
resolution [5]. The protein is L-shaped, composed of a continuous
globular N-terminal domain (Figure 1A), Domain 1, and an
elongated region consisting of three discontinuous structural
domains (Figure 1A and Figure S1A). Domains 1 and 2 are
involved in binding to cell surface receptors [6]. Domain 3 is
involved in oligomerization and contains a loop that traverses the
membrane upon pore formation [7]. Domain 4 has no known
function but contains the CTP, which is folded as 2 anti-parallel b-
strands connected by a short a-helix (Figure 1A).
To characterize the molecular interactions between the CTP
and Domain 4, we performed classical molecular dynamics (MD)
simulations. MD aims at quantitatively describing structural and
thermodynamic properties of biomolecules within physiological-
like conditions [8]. The existing potential energy models used in
MD have been shown to provide accurate representation of
atomistic interactions, and they have been used to investigate the
biophysical properties of a broad variety of molecular systems,
including the PFTs a-hemolysin from S. aureus [9,10]. To remain
as close as possible to experimental/in vivo conditions, we
performed in MD simulations at room temperature (27uC) and
atmospheric pressure (1 atm), and the proteins were solvated by
water molecules at physiological salt concentration. MD simula-
tions reported here were all based on the X-ray structures of wild
type (WT) proaerolysin (for details about the structures used, see
Methods). The loop connecting the CTP to the rest of the
molecule is however not visible in any reported crystal structure of
proaerolysin, probably due to its flexibility. Thus proaerolysin was
de facto modeled in a situation mimicking a cleaved proaerolysin
state (here after termed aerolysin-CTP). During the 200 ns of MD,
the CTP remained firmly bound to the protein (Figure 1B). Native
hydrogen bonds and salt bridges were preserved along the entire
trajectory, as were secondary structure elements, both in the CTP
and in Domain 4 (Figure 1B). The mean conservation of
secondary structure in the system, i.e. the percentage of residues
in a b-sheet conformation along the MD simulation with respect to
the initial crystal structure, was 8665% over the last 100 ns.
Since the MD simulations were performed with the absence of a
covalent bond between the CTP and Domain 4, these observa-
tions pointed to a strong binding affinity of CTP for Domain 4. By
computing electrostatic, van der Waals and solvation contributions
to the binding of CTP to Domain 4, we estimated their binding
energy to be 115 kcal/mol. Our MD-based observations thus
suggest that the CTP remains bound to aerolysin upon proteolytic
activation of the protoxin. This was confirmed using two
independent experimental approaches. First, we determined the
structure of the proteolytically processed form of an aerolysin
mutant that is unable to form heptamers, namely H132N [11].
The crystal structure of the trypsin-processed H132N mutant was
solved by molecular replacement to 2.3 A˚ resolution (PDB entry
3G4O) ([12], Protocol S1). Not only was the observed structure
very similar to that of wild-type (WT) proaerolysin (root mean
square deviation RMSD of 0.74 A˚ for subunits A and 0.92 A˚ for
subunits B in the dimer), it also contained the CTP, in an
essentially identical conformation (Figure 1C).
As a second approach to investigate whether the CTP remains
bound to the mature toxin following proteolysis, we took
advantage of our E. coli expressed WT proaerolysin, which
harbors a six-histidine tag at the C-terminus, i.e. at the end of the
CTP. When proaerolysin was incubated with Nickel beads, it
remained attached to the beads as expected and could be eluted
with imidazole but not with urea (Figure 1DE). When trypsin-
processed toxin was incubated with Nickel beads, it also remained
bound to the beads showing that the CTP had not been released
upon proteolysis. Consistently with the non-covalent interaction
between the mature toxin and the CTP, aerolysin could be
released from the beads with urea (Figure 1D).
We had previously reported that processing of proaerolysin with
trypsin leads to the release of the CTP from aerolysin [13]. This
conclusion was based on the observation that fluorescence energy
transfer was lost between a fluorescent probe, IEADANS, attached
to an engineered cysteine on the CTP at position 445 and Trp-203
in Domain 4 [13]. Our current findings suggest that the previously
observed release of the CTP was artefactually induced by the
mutation and/or labeling of the cysteine at position 445. Indeed,
in wild-type proaerolysin, Ile-445 on the CTP is buried within a
hydrophobic pocket in Domain 4 and labeling of Cys-445 with the
bulky and polar IAEDANS fluorophore (mimicked in Figure S1B)
must have triggered a severe perturbation at the CTP-Domain 4
interface, leading to premature release of the CTP upon trypsin
cleavage.
Identification of key residues for CTP–aerolysin binding
Both X-ray structures of WT proaerolysin and H132N
aerolysin-CTP show the presence of a similar complex network
of interactions between the CTP and Domain 4 composed of H-
bonds (10 in subunit A, and 16 in subunit B), salt bridges (Asp-207
with Arg-442 and Lys-198 with Glu-451), and hydrophobic
interactions. To identify key residues responsible for binding of the
CTP to Domain 4, we performed in silico alanine scanning on most
of the CTP. In silico mutation of a given CTP residue to alanine
has the effect of removing most of the native non-bonded
interactions (i.e., electrostatic and van der Waals contributions)
with the local environment. By comparing the binding free energy
of the WT species and its alanine mutant, it is possible to estimate
the individual contribution of a given CTP residues to the binding
Author Summary
Many pathogenic bacteria produce proteins, called pore-
forming toxins, designed to perforate the plasma mem-
brane of target cells thus perturbing host cell integrity and
functionality. It is, however, important that these toxins do
not form pores in the producing bacterium. To prevent
this, bacteria initially produce them in a soluble state. After
being secreted by the bacterium, the toxin subsequently
acquires – often through a multimerization step– the
ability to insert into the membrane. Here we were
interested in the mechanisms ensuring that the toxin
initially folds into the soluble state. Using as an example
aerolysin from the human pathogen Aeromonas hydro-
phila, we show that the bacterium produces the toxin with
a C-terminal extension of about 45 amino acids that
promotes the folding of the protein into the soluble state.
We find that by mutating or removing this extension, the
protein folds poorly or not at all. Addition of the peptide in
trans however lead to partial recovery of activity suggest-
ing that this extension promotes folding, and being
intramolecular thus results in a very high effective
concentration. In addition to this chaperone role for
correctly folding the monomeric form of the toxin, the C-
terminal peptide is also crucial for controlling the folding
of the quaternary structure of the mature pore complex at
the surface of the target host cell.
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affinity with Domain 4. The greater the variation, the more the
residue has a relevant role in the steady binding of the CTP to
Domain 4. As expected, mutation of solvent exposed residues
showed little variation in the binding free energy (Figure 2A). A
low but significant variation was observed for certain polar
residues, such as Asn-458, which forms a hydrogen bond with Asp-
222, Asp-448, which forms a salt bridge with Lys-198, and
especially Arg-442, which forms a salt bridge with Asp-207. The
Figure 1. The CTP remains bound to aerolysin following trypsin cleavage. A: Structure of the proaerolysin monomer as seen in the dimeric
soluble form of the toxin (1PRE). Structural domains are color coded with Domain 1 (light blue) and the large lobe of the protein additionally divided
into three domains, Domain 2 (red), Domain 3 (green) and Domain 4 (yellow). The C-terminal peptide (CTP) is shown in dark blue and the different
residues examined in this study are represented in space- filled model. B: Snapshot of Domain 4 with CTP after 100 ns of MD simulation. The main
body of Domain 4 is shown in yellow and the CTP in blue. C: Close-up of the structure of the trypsinized H132N (pdb 3G4O) showing the Fobs-Fcalc
electron density map of Domain 4 (in green) obtained prior to the reconstruction of the CTP. The map colored in blue is calculated at 2.3 A˚ resolution
and contoured at a level of 2.0A˚. The final model of the B subunit of the aerolysin mutant H132N is superimposed. D: Proaerolysin in 20 mM MES
buffer pH5, 150 mM NaCl was adjusted to pH 8 by addition of 1 M Tris buffer pH 8.7 to avoid oligomerization and subsequently was processed with
insoluble agarose trypsin beads. Unprocessed and processed toxins were incubated with His-bind resin preloaded with Nickel and incubated at 4uC
for 30 minutes to allow binding of the protein and then extensively washed. The bead sample (input) was then split in two: half was treated with 4 M
Urea (Urea) and the other half with 250 mM Imidazole (Imid.). After spinning down the beads, the supernatants were analyzed by SDS-PAGE followed
by Coomassie blue staining. E: Coomassie blue stained gels, as in C, were quantified for 3 independent experiments using ImageJ. Error bars
represent standard deviations.
doi:10.1371/journal.ppat.1002135.g001
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most dramatic variations in the binding free energy (,6 kcal/mol)
were observed for three hydrophobic residues: Leu-441, Phe-457
and Leu-462. All three residues point inside a hydrophobic pocket
in Domain 4 underlying the CTP (Figure 2B). More specifically,
Leu-441 interacts with Val-285, Ala-204, Pro-283 on Domain 4
and Leu-443 on the CTP, Leu-462 interacts with Val-217, Leu-
219, and Ile-296 on Domain 4 and Ile-414 and Leu-443 on the
CTP, and finally Phe-457 points straight into Domain 4, and is
blocked by steric hindrance with Val-197 and Leu-297 on the
Domain 4 and Ala-411 and Leu-452 on the CTP.
Mutation of Phe-457 to Gly affects both the CTP and
Domain 4
Since Phe-457 on the CTP points straight into Domain 4, we
investigated the effect of mutating this residue to glycine in silico
using an MD setup similar to the one adopted for the WT species
(Video S1). The mean conservation of the secondary structure of
the CTP drastically dropped from 76612% for the wild type to
1764% for the F457G mutant (Figure 3B). The CTP structure
remaining after the simulation was a portion of the a-helix
(Figure 3A), which we determined to be the most stable structural
element in an MD simulation of just the CTP in water (Figure
S2BC). Interestingly, the F457G mutation also affected the
underlying Domain 4 (Figure 3). Indeed, after 100 ns of MD,
the mean conservation of the secondary structure of Domain 4
(including CTP) was 8665% for the wild type and 6765% for the
F457G mutant. By computing electrostatic, van der Waals and
solvation contributions to the binding of the mutated CTP
(F457G) to domain 4, we estimated their binding free energy to be
75 kcal/mol. This represents a significant reduction with respect
to the 115 kcal/mol previously estimated from the aerolysin-CTP
MD simulation.
The effects produced by a mutated CTP on Domain 4
prompted us to compare the structural features of aerolysin with
and without its CTP. In silico, we removed the CTP from the
proaerolysin crystal structure, and 200 ns MD simulation was
performed (Video S2). Simulations performed in the presence and
absence of the CTP were subsequently compared. The structural
flexibility of each residue was quantified by calculating the root
mean square fluctuation (RMSF) of the residue along the MD
trajectory. Removing the CTP had no significant effect on the
structure of Domain 2 and 3 (Figure 4A, Domain 1 was omitted
from the simulation since it is known to act as an independent
folding unit [14]). In contrast, removal of the CTP led to an
average increase of 6.863.2 A˚ of the RMSF for a given residue in
Domain 4 (Figure 4A), suggesting that the CTP stabilizes the
structure of Domain 4. The CTP also had an influence on the
secondary structure of Domain 4. This was assessed by tracking
the percentage of secondary structure conservation along the two
simulations, i.e. the percentage of residues adopting a ß-sheet
conformation in the absence of CTP as compared to crystal
structure of proaerolysin. In the absence of the CTP, the
secondary structure conservation of Domain 4 was 67610%
(Figure 4B), compared to 8665% in the presence of CTP, and the
RMSD (root mean square fluctuation deviation) after 200 ns of
MD was 8.8 A˚, compared to 3.6 A˚ in the presence of CTP.
In silico removal of the CTP led to the unfolding of the b-strand
encompassing residues Ser-272 to Ser-280 in Domain 4
(Figure 4C). Interestingly, a further sequence-based analysis using
order prediction algorithms identified the 268-282 segment as the
most disordered region of Domain 4 (for algorithms used see
Figure 2. Molecular dynamics analysis of CTP binding. A: Residue-specific binding free energy obtained by MM-PBSA alanine scanning of CTP
residues along a single 200 ns MD trajectory of the aerolysin-CTP system. Hydrophobic interactions are shown in blue, polar interactions in red and
solvent exposed residues in grey. Higher standard deviations on solvent exposed residues Arg-442, Asp-448 and Asn-458 are due to the unstable
nature of their binding and larger fluctuation during dynamics. B: Space-filled representation of a snapshot of Domain 4 showing the hydrophobic
pocket in grey and the CTP residues involved in the hydrophobic interactions in yellow.
doi:10.1371/journal.ppat.1002135.g002
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Protocol S1) (Figure S2A), raising the possibility that the ß-
structure observed for this segment in the proaerolysin crystal
structure is in fact imposed by the CTP. It is interesting to note
that induced folding of intrinsically unstructured elements often
involves hydrophobic, rather than polar, interactions [15] as
observed here for the CTP-Domain 4 interface.
Mutation or removal of the CTP prevents folding of
aerolysin in vivo and in vitro
The above MD analyses suggest that the structure of Domain 4
strongly depends on interactions with the CTP. This raised the
interesting possibility that the CTP acts as a stabilizer or an
intramolecular chaperone during biosynthetic folding of proaer-
olysin. A prediction from this hypothesis is that when synthesized
and translocated across the inner E. coli membrane, aerolysin, i.e.
lacking the CTP, should not be able to reach a soluble form in the
bacterial periplasm. To test this, we generated constructs encoding
only the N-terminal signal sequence and the mature protein
without the CTP. Constructs were generated to express the WT
version as well as H132N as to avoid potential oligomerization in
the periplasm. As mentioned earlier, residue His-132 is required
for heptamer formation [11]. When extracts from bacteria
harboring WT or H132N aerolysin-DCTP expression constructs
were analyzed by SDS-PAGE and Coomassie blue staining, a
band migrating at the expected <50 kDa molecular weight was
observed upon induction with IPTG, showing that bacteria were
able to produce aerolysin-DCTP and that the protein was not
degraded by periplasmic proteases (Figure 5 AD). When bacteria
were processed to generate periplasmic and spheroplast fractions,
proaerolysin, which migrates at <52 kDa, was recovered in the
periplasmic fraction. In contrast WT or H132N variants of
aerolysin-DCTP were only recovered in the spheroplast fraction
(Figure 5 AD). Care was taken to induce toxin expression with a
low IPTG concentration (0.25 mM) at a bacterial density of
OD600 nm = 0.6 for only 2 hrs at 18uC, to avoid jamming of the
translocation machinery across the inner membrane and impair
periplasmic folding. That periplasmic translocation of both
proaerolysin (Figure 5B upper panel) and aerolysin-DCTP
(Figure 5B lower panel) did occur under these conditions was
confirmed by Western blot analysis. A weak band corresponding
to pre-proaerolysin, i.e. protein for which signal sequence cleavage
had not yet taken place, could be observed in the spheroplast
fractions (Figure 5B). The bulk of both proaerolysin and aerolysin-
DCTP however underwent processing by signal peptidase
confirming that both forms of the toxin were properly translocated
across the inner membrane (Figure 5B).
Our in silico alanine scanning analysis (Figure 2A) predicted that
mutation of Leu-441, Phe-457 and Leu-462, and to a lesser extent
Arg-442, to alanine should affect binding of the CTP to Domain 4.
To test these MD-based predictions, we generated constructs to
express these mutants in the E. coli periplasm. We also sought a
mutation that would affect the secondary structure of the CTP but
not the binding. We chose to change Ser-453 to proline since this
residue localizes to the middle of the a-helix of the CTP (Figure 1A)
and does not make contacts with Domain 4. In agreement, in silico
mutation of Ser-453 to alanine did not lead to a significant variation
in the binding free energy (Figure 2A). Due to the folding of its side
chain back onto the protein backbone, proline imposes severe
constraints to the backbone geometry leading to helix breaking.
All proaerolysin mutants were detected in bacterial extracts
showing that they were synthesized and not degraded to any
significant extent (Figure 5B). Proaerolysins L441A, R442A and
L462A were recovered in significant amounts in the periplasmic
fraction (Figure 5D). Proaerolysin S453P was barely detectable in
the periplasmic fraction (Figs. 5CD), but following purification low
amounts of the protein could be obtained. Proaerolysins F457A/G
were essentially undetectable in the periplasmic fraction
(Figs. 5CD) and neither could be recovered following purification
on Nickel columns. These observations show that mutating Ser-
453 to proline or Phe-457 to glycine induced aggregation of
proareolysin in the bacterial periplasm, either due to the exposure
of a hydrophobic patch or improper folding of part of the protein.
Figure 3. Mutation of Phe-457 affects the structure of the CTP and Domain 4. A: Representative snapshot of Domain 4 and CTP interactions
in the F457G mutant system after 100 ns of MD simulations. Residue 457 is shown in ball-and-stick representation. B: The percentage of secondary
structure conservation for the CTP (solid lines) and for Domain 4 (dashed lines) is reported. Conservation is higher for WT system (black) than for the
F457G mutant (red).
doi:10.1371/journal.ppat.1002135.g003
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The small amounts of toxin that could be purified for all mutants
was however properly folded as indicated by the WT-like
hemolytic activity of the mutants following trypsin cleavage
(Figure 6AB).
We next investigated the in vitro folding of the mutant
proaerolysins. For this, proaerolysins, WT and mutants, were
unfolded in urea. We have previously shown that proaerolysin
unfolding in urea or GdnHCl occurs in two steps, corresponding
to the unfolding of Domains 2 to 4, followed by the unfolding of
the highly stable Domain 1 [14] (Figure S3AB). All four
proaerolysin mutants showed very similar urea unfolding curves
(Figure S3C). Following unfolding in 4 M urea, refolding of
proaerolysins was triggered by dilution in a urea-free buffer. The
efficiency of folding was indirectly monitored by measuring the
hemolytic activity of the refolded proaerolysins after proteolysis
with trypsin (trypsin was added 5 min after dilution in the urea
free medium). Hemolysis was followed as a function of time.
Under these conditions, refolded L441A and S453P systematically
showed a delayed hemolytic activity (Figure 6C). These experi-
ments reveal that in vitro folding into a soluble state of the L441A
and S453P proaerolysin mutants was impaired and the extent
correlated with the ability of the mutants to fold into a soluble state
in vivo (Figure 5).
Altogether, these computational analyses and experimental
observations indicate that the CTP is required for proper folding
of aerolysin and that both the structure of the CTP and its binding
affinity to Domain 4 are important for proaerolysin to reach a
soluble active state.
The aerolysin CTP promotes folding to a soluble state
both in cis and in trans
Since aerolysin without the CTP could not be purified from
bacteria, we studied the folding of aerolysin by cleavage of
proaerolysin with trypsin followed by unfolding in urea. Unfolding
transitions occurred at similar concentrations of chaotropic agents
whether proaerolysin was processed by trypsin or not, suggesting
proaerolysin and aerolysin-CTP have similar stabilities.
Refolding was initiated by dilution into a urea free buffer and
the tryptophan emission spectrum was measured at different times
for more than 24 hrs. The maximum emission wavelength of
proaerolysin rapidly shifted from 344 nm, corresponding to the
unfolded protein, to 336 nm, corresponding to that of native
proaerolysin. Under refolding conditions, the maximum emission
wavelength of aerolysin –which had presumably lost its CTP
during unfolding– however failed to reach that of native aerolysin-
CTP, indicating that refolding did not occur or was partial. This
Figure 4. Removal of the CTP results in partial unfolding of Domain 4. A: Structural fluctuation per residue (calculated as RMSF) during the
MD simulations of WT aerolysin with and without CTP. B: Comparison of the secondary structure conservation ratio for Domain 4 with (black) and
without (red) the CTP. C: Representative snapshot of Domain 4 in WT aerolysin in the absence of the CTP after 100 ns of MD simulation. The coloring
scale reports the degree of disorder as estimated using a set of disorder predictors (blue: mostly ordered; red: mostly disordered, see also Protocol
S1).
doi:10.1371/journal.ppat.1002135.g004
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Figure 5. Removal or single point mutations of the CTP affect the folding of aerolysin in vivo. A: WT and H132N aerolysin, with and
without the CTP, were expressed in the periplasm of E. coli upon induction with IPTG. Cell extracts were analyzed by SDS-PAGE and Coomassie blue
staining before and after induction, as were the periplasmic (perip.) and the remaining spheroplast (sphero.) fractions. B: WT toxin, with and without
the CTP, was expressed in the periplasm of E. coli upon induction with IPTG. Cell extracts, periplasmic and spheroplast fractions were analyzed by
western blotting against aerolysin, revealing the signal peptidase dependent processing of signal peptide harboring precursors. C: WT and mutant
proaerolysin were expressed in the periplasm of E. coli. Bacterial extracts and periplasmic fractions were analyzed by SDS-PAGE and Coomassie blue
staining as in A. D: The amount of toxin present in cell extracts after IPTG induction as well as in the periplasmic fraction were quantified for 3
independent experiments using ImageJ (n = 3). Error bars represent standard deviations. Periplasmic toxin was normalized to the amount of toxin in
the cell extracts. **: p,0.005.
doi:10.1371/journal.ppat.1002135.g005
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was confirmed by circular dichroı¨sm (CD) in the far UV, which
allows monitoring of secondary structure. As described previously,
proaerolysin and aerolysin-CTP have very similar far UV CD
spectra (Figure 7A) [16]. Upon unfolding and refolding, the
spectrum of proaerolysin was to a large extent recovered
(Figure 7A). In contrast, the spectrum of aerolysin under refolding
conditions showed typical features of a random coil, with a strong
negative ellipticity in the 200 nm spectral region possibly due to
protein aggregation (Figure 7A). Thus, aerolysin was unable to
reach a soluble state in vitro confirming the in vivo experiments
(Figure 5 AD). Interestingly, under refolding conditions, aerolysin
did not fold into a molten globule-like structure, which has native
like secondary structure (Figure 7A). That aerolysin failed to reach
a native conformation in vitro was confirmed by the lack of
hemolytic activity after refolding from .4 M urea, in contrast to
proaerolysin which refolded properly even from .6 M urea
(Figure 7B).
All of the above-described observations point towards a role of
the CTP in promoting the folding of proaerolysin into a soluble
protein during biosynthesis. We finally investigated whether the
CTP could also act when added in trans during in vitro refolding of
aerolysin. We found that addition of 5-fold molar excess of
synthetic CTP led to a significant and reproducible recovery in
hemolytic activity of aerolysin, whereas addition of an irrelevant
peptide did not (Figure 7C). The fact that rescue was only partial is
not surprising since having a covalently bound CTP, as in
proaerolysin, greatly increases the effective concentration of the
peptide, a situation that cannot be mimicked by ectopic addition of
excess CTP.
CTP prevents aerolysin oligomerization
It had previously been proposed for Clostridium a-toxin, a toxin
with 27% sequence identity and 72% similarity to aerolysin, that
the role of the CTP is to inhibit the oligomerization process [17].
We found that this role is also fulfilled by the aerolysin CTP.
Proaerolysin was cleaved in vitro with trypsin and oligomerization
was allowed to proceed in the absence or presence of a five-fold
excess of either synthetic CTP or a control peptide. Heptamer
formation was delayed by the presence of CTP (Figure 8AB). The
role of the CTP in oligomerization was confirmed by the following
observation. When proaerolysin was processed by trypsin in a
pH 8 buffer to avoid oligomerization [11] and subsequently
dialyzed against a neutral pH buffer to allow oligomerization,
heptamer formation was only observed with a dialysis cut off that
allowed the passage of the CTP (14 kDa) but not with a cut off that
retained the CTP (3.5 kDa) (Figure 8C). Thus the binding of the
CTP to Domain 4 inhibits oligomerization.
Weaker CTP binding promotes oligomerization
A corollary of the observation that the CTP inhibits
oligomerization is that the CTP must be displaced from the
mature protein for the process to occur and thus that weaker CTP
binding should promote oligomerization. We first tested whether
the S453P CTP would be released more readily than the WT
CTP. To address this issue, WT and S453P proaerolysins were
bound to Nickel charged NTA Surface plasmon resonance (SPR)
sensor chips –via the His-tag at the C-terminus of the CTP– and
cleavage of the CTP was induced by trypsin addition. After trypsin
addition, a strong loss of signal was observed (Figure 9A),
presumably corresponding to the release of the mature toxin from
the chip-bound CTP. From these curves, we estimated an
apparent Koff of 4.5.10
2360.6.1023 s21 for WT and
2.6.102260.4.1022 s21 for S453P, confirming that the off rate
of the S453P CTP was about 10 times higher than that of the WT
CTP. These Koff values should, however, only be considered in a
comparative and not an absolute manner. The structure of
Figure 6. Hemolytic activity of WT and mutant aerolysins. A. WT and mutant proaerolysins were processed with soluble trypsin, added to
erythrocytes at 20 mg/mL and the transmitted light at 600 nm of the sample was followed at room temperature as a function of time. Plots represent
the percentage of transmitted light as recorded by the SpectraMax ME as a function of time. This is a representative experiment out of 4 independent
experiments. B: WT and mutant proaerolysins (2 mg/mL) were processed with soluble trypsin, then subjected to a serial dilution (1/2) in a 96 well
plate and incubated with erythrocytes. The number of wells lysed after 60 min at room temperature was determined. Error bars represent standard
deviations (n = 3). C: WT and mutant proaerolysins (2 mg/mL) were unfolded in 4 M urea for 2 hrs, diluted 10 fold in a urea free medium. After 10 min,
samples were treated with trypsin for 10 min. Erythrocytes were added and the transmitted light at 600 nm of the samples was followed at room
temperature as a function of time. This is a representative experiment out of 5 independent experiments.
doi:10.1371/journal.ppat.1002135.g006
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aerolysin H132N and the experiments of binding WT aerolysin-
CTP to Nickel beads (Figure 1DE) indeed show that the WT CTP
does not come off over a period of several hours, which is
inconsistent with a Koff in the order of 10
23 s21. Binding of the
CTP to the SPR chip therefore appears to have induced an
accelerated release.
That the S453P CTP has a lower affinity for the mature toxin
was confirmed by the observation that upon binding of S453P
aerolysin-CTP to Nickel beads, about 40% of the total aerolysin
was recovered in the unbound fraction (Figure 9BC), i.e. it was
released from the bead-bound CTP, whereas less than 10% of the
aerolysin was released when performing a similar experiment with
the WT toxin (Figure 1DE). Importantly, the CTP-free aerolysin
fraction recovered from the S453P-treated beads had the same
hemolytic activity as WT proaerolysin treated with trypsin (961
wells lysed in 60 min for CTP-free aerolysin (n = 3) and 860.5 for
trypsin treated WT proaerolysin, see methods). Three important
conclusions can be drawn from this observation: 1) the CTP is not
required for pore formation, confirming our previous findings
[13]; 2) CTP-free aerolysin does not unfold –but might change
conformation– since it retains its full activity; 3) CTP-free aerolysin
does not undergo unproductive aggregation, thus the role of the
CTP is not merely to prevent aggregation of monomers.
If CTP release is necessary for oligomerization, then oligomer-
ization should be accelerated when CTP binding is weaker. This is
indeed what we observed when comparing oligomerization of WT
and S453P: upon trypsin cleavage of S453P proaerolysin,
oligomerization occurred faster than for WT (Figure 10AB).
To our surprise, we found that S453P actually already showed
some hemolytic activity even in the absence of trypsin cleavage
(Figure 10C), which is never observed for WT proaerolysin. This
activity was some 15 fold lower than upon trypsin cleavage, yet
significant and reproducibly detectable. Hemolytic activity in the
proaerolysin form was also observed for the other CTP mutants
L441A, R442A and L462A, but to a lesser extent (Figure 10C).
These observations show that cleavage of the loop linking the CTP
to Domain 4 is not essential and that peptide displacement is
sufficient.
Discussion
Guided by a combination of molecular simulations and in silico
mutagenesis analysis and using a combination of structural and
functional assays on WT and mutant toxins, we show that the
CTP is essential for the folding of aerolysin into a soluble toxin.
Due to the fact that it promotes folding but is not part of the final
active conformation of the protein, i.e. the transmembrane
heptameric pore, the CTP qualifies as a chain-linked molecular
chaperone [18]. Chaperones comprise both proteins that favor the
folding reaction of substrate proteins and proteins that control the
quaternary assembly of multisubunit complexes. These two
distinct roles can also be found in chain-linked, or intramolecular,
chaperones and have been termed type I (folding) and type II
(assembly) intramolecular chaperones [18]. Chain-linked chaper-
ones can be short peptides (<40 residues) or independent folding
units. They are often found in secreted or transmembrane
proteins, a situation that requires the protein to be translocated
across the plasma membrane in prokaryotes (as for proaerolysin)
or the ER membrane in eukaryotes. As discussed below, due to the
directionality of membrane translocation coupled to protein
synthesis, type I intramolecular chaperones are found at the N-
terminus of proteins. However, exceptions, such as aerolysin, exist.
Indeed, an N-terminal chaperone prevents misfolding a priori,
while a C-terminal chaperone would act a posteriori. In contrast,
most documented type II intramolecular chaperones are C-
terminal. Irrespective of their localization, chain-linked chaper-
ones should not be part of the final structure, which implies that
they must be cleaved off at some point.
One of the earliest and best-characterized examples of a protein
with an N-terminal intramolecular chaperone is Bacillus subtilis
subtilisin, in which the 77 first amino acids fold into a well defined
domain promoting the folding of the next 275 residues, acting as a
type I chaperone, and is subsequently cleaved off by autoproteo-
lysis [19].
C-terminal intramolecular chaperones have also been de-
scribed. They are, however, generally of the type II, playing a
role in controlling the quaternary assembly of proteins such as tail
Figure 7. The CTP is required for refolding of aerolysin in vitro. A: Circular dichroı¨sm spectra were measured between 195 and 250 nm in
20 mM Hepes, 50 mM NaF pH 8 at 20uC. The spectra were acquired for proaerolysin before (blue) and after processing with trypsin (red, labeled
aerolysin-CTP). Proteins were unfolded in 4 M urea, refolded by 10 fold dilution in a urea free buffer and the spectra of Refolded proaerolysin (yellow)
and Refolded aerolysin (which has lost its peptide by unfolding) (green) were acquired after 1 hr at room temperature. B: Proaerolysin was subjected
to proteolysis (red) or not (blue), unfolded in between 0 M and 6.3 M urea for 2 hrs and allowed to refold in urea free buffer before the hemolytic
activity was assessed. Proaerolysin was processed with trypsin after refolding. The results are the mean of 3 independent experiments. Error bars
represent the standard deviation. C: Proaerolysin (0.5 mg/mL) was or not processed with trypsin agarose beads. Upon bead removal, the protein was
unfolded in 4 M urea at room temperature for 12 hours. Refolding was performed by dilution into a urea free buffer in the presence or absence of a
5-fold molar excess of CTP or control peptide. The hemolytic capacity was determined by serial dilution of the toxins and incubation with
erythrocytes for 24 hrs.
doi:10.1371/journal.ppat.1002135.g007
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spikes of bacteriophages or fiber forming collagen [18]. Examples
of type I C-terminal chaperones are rare and evidence is
circumstantial [20,21,22,23]. Aerolysin thus appears to be the
first example of a protein bearing a C-terminal chain-linked
chaperone promoting the formation of soluble monomeric
subunits and controlling assembly of the active complex, i.e. both
type I and type II. The present studies indeed show that the
aerolysin CTP acts as a type II chaperone in controlling the onset
of heptamerization, a role consistent with its C-terminal location.
More unexpectedly, we found that the CTP drives formation of
soluble proaerolysin. Mutations in the CTP that affects its
structure (S453P) or its binding to Domain 4 (L441A, F457G)
indeed lead to aggregation of proaerolysin both in vivo and in vitro.
Moreover aerolysin, devoid of CTP, also aggregated. Importantly,
addition in trans of a 5 fold molar excess of synthetic CTP allowed
partial recovery of activity. Upon CTP release, the trigger for
which remains to be established, aerolysin remains folded, possibly
with a somewhat different conformation, as illustrated by the full
hemolytic activity of CTP-free aerolysin obtained from the S453P
mutant. The unaltered activity of CTP-free aerolysin also indicates
that the CTP plays a role in the biogenesis of the toxin and does
not prevent unproductive aggregation of protein once folded.
Altogether, these observations thus classify the aerolysin CTP as a
chain-linked intramolecular chaperone.
Our observations clearly indicate that the CTP prevents
aggregation of proaerolysin during biosynthetic folding. As
mentioned above, and as supported by the ability of the CTP to
promote recovery of hemolytic activity upon in vitro folding of
Figure 8. Aerolysin oligomerization is controlled by the CTP. A: Proaerolysin was activated with trypsin agarose beads at 4uC in a Tris pH 8
buffer to inhibit oligomerization and the sample was diluted with 50 mM Hepes pH 7 to a concentration of 10 mM in order to favor oligomerization in
the presence or absence of a 5-fold molar excess (i.e. 50 mM) of synthetic CTP or control peptide. The sample was incubated at room temperature for
different times and subsequently analyzed by SDS-PAGE followed by Coomassie blue staining. B: The amount of oligomer was quantified for 3
independent experiments using ImageJ (n = 3). Error bars represent standard deviations. C: Proaerolysin at a concentration of 1 mg/mL in a buffer at
pH 8 (to inhibit oligomerization) was activated with trypsin agarose beads and subsequently dialyzed against 10 mM Hepes buffer pH 7.4, 10 mM
NaCl to initiate the oligomerization process. Two different dialysis molecular weight cut offs where used: 14 kDa, which allows the passage of the
CTPs and 3.5 kDa, which retains peptides the size of the CTP. After 2 hours of dialysis at RT, the samples were analyzed by SDS-PAGE followed by
Coomassie blue staining.
doi:10.1371/journal.ppat.1002135.g008
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aerolysin, the CTP appears to do more than merely preventing
aggregation as also suggested by the molecular dynamics studies.
Confirming that the CTP promotes the folding of aerolysin and
how it does so will require further investigation. Since
proaerolysin is translocated from N- to C-terminus when crossing
the inner Aeromonas membrane, the CTP appears last. In
particular, it appears some 250 residues later than some of the
residues it interacts with. What is also puzzling is that the CTP is
not an independent folding unit that could guide folding of the
rest of the protein, as is the case for most type I intramolecular
chaperones. Our MD simulations suggest that when released
from the protein, as mimicked by the F457G mutation, or when
free in solution, the CTP is largely unfolded (Figure S2BC).
Therefore the CTP might stabilize folding intermediates. It has
been proposed that, as a protein follows its folding landscape, the
chaperone domain binds to, stabilizes and increases the
population of molecules with native conformations. Thus, as
opposed to general chaperones, which are thought to lack any
structural information about the protein they fold, dedicated
chaperones and possibly the aerolysin CTP could promote
folding via conformational selection [24,25,26] and thus convey
steric information. This hypothesis is consistent with the
observation that one segment of Domain 4 with which the
CTP interacts in the final structure, residues 269–279, is
predicted to be unstructured. Even though largely unfolded,
such segments are likely to fluctuate between multiple folded
states during short times, one of which could be stabilized by the
CTP. A prediction from the conformational selection model for
CTP-mediated proaerolysin folding is that folding should be
affected by mutations in the CTP. This is indeed what we
observed for the mutants suggested by in silico alanine scanning
mutagenesis and in particular for the S453P and F457A/G
mutations.
As mentioned above, the CTP appears to force segment 268–
272 into a b-strand conformation. Importantly, this segment is
directly followed by the loop in Domain 3 that is to form one of
the amphipathic ß-hairpins of the heptameric transmembrane ß-
barrel pore (Figure S2A). The ability of the CTP to control the
folding state of the underlying b-strands (note that Domain 4
shares multiple b-strands with Domains 3 and 2) suggests that the
peptide also acts as a switch to control the pore formation
process. Our observations indeed show that CTP release
promotes oligomerization and that the CTP is not part of the
final pore. Future studies will address what triggers release of the
CTP. Our preliminary observations indicate that specific
detergents can displace the CTP, consistent with the importance
of hydrophobic interactions in CTP binding and suggesting that
the target cell membrane may play a role. Future studies will also
address whether CTP release triggers partial unfolding of
Domain 4 and whether these changes propagate to Domain 3
helping overcome the energy barrier that leads to formation of
the heptamer, the most thermodynamically stable conformation
[14].
Figure 9. The S453P mutation leads to premature release of
the CTP. A: Surface plasmon resonance analysis of mature toxin
release following binding of His-tagged WT and S453P proaerolysin to
Nickel charged sensor chip and trypsin addition. Release of the mature
protein was observed following the addition of trypsin. B: S453P
Proaerolysin in a 50 mM Tris 50 mM NaCL pH 8 buffer was processed
with insoluble agarose trypsin beads. Unprocessed and processed
toxins were incubated with His-bind resin preloaded with Nickel and
incubated at 4uC for 30 minutes to allow binding of the protein and
then extensively washed. The bead sample (input) was then split in two:
half was treated with 4 M Urea (Urea) and the other half with 250 mM
Imidazole (Imid.). After spinning down the beads, the supernatants
were analyzed by SDS-PAGE followed by Coomassie blue staining. C:
Coomassie blue stained gels, as in B, were quantified for 3 independent
experiments using ImageJ. Error bars represent standard deviations.
doi:10.1371/journal.ppat.1002135.g009
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Figure 10. Effect of the S453P mutation on oligomerization and activity. A: WT proaerolysin, kept in 20 mM Mes 150 NaCl pH 5, was diluted
2 fold with a 20 mM Tris 150 NaCl pH 8 buffer while S453P proaerolysin, kept in 20 mM Tris 150 NaCl pH 8, was diluted 2 fold with a 20 mM Mes 150
NaCl pH 5 buffer. Following dilution this dilution (final toxin concentration 0.4 mg/ml), the samples were processed on ice with trypsin and then
incubated at room temperature to allow oligomerization. Aliquots were removed at different times and the extent of oligomerization was monitored
Propeptide Driven Folding of Proaerolysin
PLoS Pathogens | www.plospathogens.org 12 July 2011 | Volume 7 | Issue 7 | e1002135
Methods
Proaerolysin production
Proaerolysin WT and mutants were expressed using a pET22b
vector (Novagen), which allows periplasmic expression of the toxin
with a His6 tag on the C-terminus, as described [7]. Mutagenesis
was carried out using the Quick Change Kit (Stratagene). Briefly,
BL21 [DE3] pLysS E. coli harboring the WT or mutant aerolysin
expression plasmid were grown at 37uC to an OD600 of 0.6. IPTG
(0.25 mM) was added and cultures were shifted to 16uC for
protein production. Cells were harvested after<2 hrs (reaching an
OD600 = 1.2). Periplasmic fractions were isolated by resuspending
cells in T Buffer (0.1 M Tris-HCl pH 8.0, 18% sucrose) containing
5 mM EDTA and 0.2 mg/mL lysozyme. After agitation for
30 min at 4uC, the periplasm and spheroplasts were separated by
centrifugation. For purification, the supernatant was further
ultracentrifuged (100 000 x g for 2 h at 4uC), filtered (0.45 mm)
and dialyzed against 20 mM sodium phosphate buffer pH 7.4,
0.5 M NaCl and loaded on a 1 mL HiTrap chelating column
(Amersham Pharmacia Biotech) running on an AKTATM prime
FPLC workstation. The protein was eluted in a 20 mM sodium
phosphate buffer pH 7.4, 0.5 M NaCl buffer with a linear
gradient of imidazole (0–0.5 M). Finally, fractions containing the
protein were dialyzed against 20 mM MES buffer pH5, 150 mM
NaCl before snap freezing and storing at 280uC. Protein
concentration was determined by O.D.280 measurements using
an estimated e<13.05?104 M21?cm21. The S453P single point
mutant was dialysed into 20 mM Tris 150 mM NaCl pH 8
following purification due to its tendancy to oligomerizes
unprocessed when dialyzed into the MES pH 5 buffer.
Trypsin cleavage of proaerolysin
Unless specified, processing of proaerolysin was performed by
addition of 1/100 (weight/weight) of soluble trypsin (Sigma) and
incubation for 10 min at room temperature. Where specified, the
proaerolysin containing solution of 20 mM MES buffer pH5,
150 mM NaCl was adjusted to pH 8 by addition of 1 M Tris
buffer pH 8.7 to avoid oligomerization [11]. Pre-washed trypsin
immobilized on agarose beads (Sigma) was added to the
proaerolysin sample at 4uC and incubation was allowed to
proceed on a rotary shaker for 2 hrs. The trypsin agarose beads
were removed by centrifugation at 7000 rpm in a tabletop
Eppendorf centrifuge. The degree of activation was assessed by
SDS-PAGE and Coomassie blue staining.
Hemolytic activity
Activity of aerolysin was defined by its ability to lyse red blood
cells. Serial dilutions of aerolysin starting at 20 mg/ml were
incubated with a 0.5% solution of red blood cells in a 96 well plate.
Activity was either recorded as number of wells fully lysed in
60 min at room temperature [7] or as the transmitted lightof the
erythrocyte suspension monitored at 600 nm as a function of time
in a given well using an automated 96 well plate reader at 37uC.
Peptide inhibition of oligomerization
Proaerolysin at a concentration of 0.4 mg/mL was submitted to
proteolysis with trypsin bound to agarose beads as described
above. A 5 fold mol/mol excess of synthetic propeptide
(EzBiolabs), control peptide, or an equal volume of buffer, was
added to the sample. To initiate the oligomerization process
(which requires a pH,8 and is promoted by low salt), the sample
was dialyzed at 4uC against 10 mM Hepes buffer pH 7, 10 mM
NaCl for 2–4 hours. The dialysis molecular weight cut off was 3.5
kDa, unless specified otherwise. Aliquots were removed at different
time points and subjected to SDS-PAGE.
Unfolding, circular dichroism and tryptophan
fluorescence measurements
Tryptophan fluorescence was measured as described [14] using
a SpectraMax M2e spectrofluorimeter. Circular dichroism (CD)
measurements were performed at 20uC using a Jasco J815
spectrometer using quartz cells of 0.01 cm path length [13].
Spectra between 190 and 250 nm were recorded in 20 mM Hepes
buffer pH 8, 50 mM NaF at protein concentrations between 0.1–
0.3 mg/mL.
For unfolding, proaerolysin WT or mutant or aerolysin was
incubated in 4 M urea (see Protocol S1). Refolding was triggered
by 1:10 dilution into urea free buffer. The refolding reaction was
assessed by circular dichroism or hemolytic activity. The buffer
blank solution was obtained by dilution of the respective buffers.
Structural models and molecular dynamics simulations
WT proaerolysin in its dimeric form has been crystallized with a
resolution of 2.8 A˚ (entry 1PRE in protein databank). In this
crystal structure, two loops located on top of Domain 4 proved too
flexible to be crystallized, namely residues 207 to 211 and 423 to
439. A crystal structure of dimeric proaerolysin mutant Y221G has
been obtained with a higher resolution of 2.2 A˚ (entry 3C0N in
protein databank). In this crystal, residues 207 to 211 could be
mapped in the crystal structure but loop 423 to 439 is still missing.
This loop connects the CTP to the rest of the protein, and contains
the site where cleavage takes place during aerolysin activation
(420–427).
A model of wild-type aerolysin with the propeptide bound
(labeled aerolysin-WT) to use in molecular dynamics simulations
was obtained by using 3C0N structure, and mutating residue 221
back to tyrosine using 1PRE as a structural template (wild-type
rebuilding did not caused any steric problem since 3C0N and
1PRE were virtually identical). We assumed that this model would
mimic the aerolysin structure after cleavage, i.e. C-terminal
propeptide no longer covalently connected to the protein, but still
bound to it. In fact, this model is structurally equivalent to the
cleaved aerolysin H132N X-ray structure showed in this work. We
modeled active aerolysin (labeled WT) by removing the propeptide
from the previous model. Mutation F457G has been performed by
removing the Phe-457 side-chain.
Aerolysin contains six histidines. Their protonation state at
physiological pH has been defined by the presence of proton
donors and acceptors in their neighborhood in the crystal
structure. We concluded that in H107, H121, H132, H186 and
H332 Ne atom is protonated, whereas in H341 Nd is protonated.
These model systems were solvated in a rectangular box of pre-
equilibrated TIP3P water molecules, and their total charge was
neutralized by the addition of Na+ and Cl2 counterions.
by SDS-PAGE and Coomassie blue staining. B: Coomassie blue stained gels, as in A, were quantified for 3 independent experiments using ImageJ.
Error bars represent standard deviations. C: WT and mutant proaerolysins, in the absence of any protease treatment, were added to erythrocytes at
2 mg/mL and the transmitted light at 600 nm of the sample was followed at room temperature as a function of time. Plots represent the percentage
of transmitted light as recorded by the SpectraMax ME as a function of time. This is a representative experiment out of 4 independent experiments.
doi:10.1371/journal.ppat.1002135.g010
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Molecular dynamics has been performed for aerolysin with CTP
(labeled Aero-CTP), without CTP (labeled Aero) and mutation
F457G using the Amber parm99sb force field [27] on NAMD
molecular dynamics engine [28], using the SHAKE algorithm on
all the bonds, and Particle-mesh Ewald for treating the
electrostatic interactions in periodic boundary conditions [29].
We used an integration time step of 2 fs. The systems were energy-
minimized by means of 1000 conjugate gradient steps, and
subsequently gradually heated from 0 to 300 K in 1 ns at 1 atm.
Simulations were run in the NPT ensemble at 1 atm and 300 K.
Temperature was controlled by means of Langevin forces, using a
damping constant of 1 ps-1.
Preliminary results confirmed that Domain 1 is bulky and, being
connected by a long random coil to the large lobe (Figure 1A),
extremely flexible with respect to the rest of the protein. Since this
resulted in no influence on the structure of the other domains, we
decided to remove it in order to reduce the system size and
therefore speed up the remaining computation. All simulations
were run for at least 200 ns. RMSD of MD simulations showed
that every system equilibrated in around 10 ns.
Alanine scanning was performed on the single 200 ns molecular
dynamics trajectory of CTP-WT system. A subset of 200
decorrelated frames (one every 10 ns) was extracted. On this
subset, we calculated binding free energies of Ala mutant species
using the MM-PBSA method, as implemented in the AMBER
molecular dynamics package (24). The Poisson-Boltzmann method
was used to compute the electrostatic contribution to the solvation
free energy. Ionic strength molarity was set to 0.1 M, the protein
dielectric constant to 1, and the solvent to 80. Every residue being
part of the CTP, excluding glycines and prolines, was scanned.
These residues play a major role in the determination of strand
flexibility, thus the alanine scanning is known to perform poorly.
The MM-PBSA method was also used to estimate the binding free
energy of WT and F457G mutated CTP to domain 4. For both
these measures, 200 decorrelated frames extracted from aero-CTP
and F547G MD simulations were used, respectively. Analysis of
MD trajectories, as well as rendering of protein structures, has
been performed using VMD [30].
Supporting Information
Figure S1 A: Sequence of the pre-pro-aerolysin used in this
study. The periplasmic secretion motif is colored black and the
different domains of the proteins are color-coded cyan (Domain 1),
red (Domain 2), green (Domain 3) and orange (Domain 4). The
CTP is shown in blue with the residues described in this study
shown in bold. The flexible linker connecting the CTP to the
Domain 4 of the protein is shown in bold. B: Two points of view of
proaerolysins with Ile-445 mutated to cysteine to which IEADANS
has been attached.
(TIF)
Figure S2 A: Disorder predictions performed using eight
different prediction algorithms on the proaerolysin sequence. In
red, the region spanning Gln-268 to Arg-282 was predicted by at
least six algorithms to be disordered. BC: Secondary structure
along a 195 ns MD simulation in explicit water of CTP (from
crystal structure 1PRE). B: Time vs CTP residues. A black area
indicates that a residue is part of an a-helix at a given time. On the
left side is a cartoon representation of the CTP structure with
arrows depicting beta-strands and rectangle representing alpha
helix. C: MD snapshots taken every 50 ns. Snapshot at time zero is
colored according to the percentage of time every residue spends
being part of an a-helix: red areas are mostly helical, blue areas
are not. Residues 449 to 454 (i.e. the alpha helix in the crystal
structure) spend,70% of the time in a-helix, and appear to be the
only structured region of CTP.
(TIF)
Figure S3 AB: Pro (black) and activated (grey) aerolysin samples
(20 mM) were incubated with different concentrations of GdnHCl
(A) or urea (B) for 2 hrs. Activation was performed prior to
unfolding with trypsin agarose beads that were subsequently
removed. Fluorescence was measured with an excitation wave-
length of 280 nm and the fluorescence emission intensity ratio at
345/315 nm was determined and plotted as a function of urea
concentration. C: Urea unfolding curves of WT and different CTP
mutant proaerolysins described in this study (as in A).
(TIF)
Video S1 Molecular dynamics simulation of proaerolysin
F457G. Result of a molecular dynamics simulation of proaerolysin
F457G. The secondary structure of every frame, as calculated by
the DSSP algorithm, is represented in the cartoon with different
colors: yellow is beta sheet; white and cyan are random coil;
purple, blue, and red are alpha helix). Mutation F457G, located
on the CTP, has a destabilizing effect. Indeed, the CTP loses most
of its secondary structure and begins to disconnect from Domain
4. On Domain 4 an unfolding similar to the one observed in the
absence of CTP can be detected. The movie was rendered using
the VMD software.
(MP4)
Video S2 Molecular dynamics simulation of aerolysin WT
without the CTP. Result of a molecular dynamics simulation of
aerolysin WT with CTP manually removed. The secondary
structure of every frame, as calculated by the DSSP algorithm, is
represented in the cartoon with different colors: yellow is beta
sheet; white and cyan are random coil; purple and blue are alpha
helix. Two strands unfold from Domain 4 in the direction of the
loop region in Domain 3.
(MP4)
Protocol S1 Are described the protocols for Crystallization,
structure determination and refinement of the H132N aerolysin
mutant, Unfolding and refolding measurements, Disorder predic-
tion algorithms
(DOC)
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